External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
Key facts
- Who runs it
- University of Pennsylvania
- Where
- Philadelphia, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 10 people, planned
- Started
- 4 Jan 2026
- Expected to end
- 1 Jul 2028
- Type of study
- Interventional
- Treatments tested
- Thoracic duct drainage
- Record updated
- 18 February 2026
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- Adult (18-80 years) patients in Surgical ICU with suspected or documented infection on antibiotics and septic shock defined as hypotension requiring vasopressor therapy to maintain MAP > 65mmHg (modified from Sepsis-35); Participants will fulfill the inclusion criteria not only at recruitment and consent, but also be confirmed to still meet those criteria immediately prior to transfer to IR for the procedure; The patient will not be recruited if he or she no longer meet these criteria; Patients experiencing hemodynamic instability, defined as (1) MAPs < 65 despite ongoing up-titration of pressors and volume resuscitation or (2) active titration of vasopressors (more than 2 increases in past hour) or active volume resuscitation (more than 1-liter bolus in past hour) that precludes travel to IR during the intervention window will be excluded from the study and considered screen fails
Who cannot take part
- Prior instrumentation of the lymphatic system
- Previous left axillary node dissection ± left upper limb lymphoedema
- Immunocompromised state (active cytotoxic chemotherapy or transplant recipient)
- Subject or authorized representative not willing to provide consent (unconscious patient will need to countersign prior to analysis of samples)
- Class 4 heart failure
- Any chronic medical condition for which the patient is expected to have <6-month survival
- Decompensated liver failure with ascites
- Portal hypertension with history of variceal bleeding
- Severe allergy to contrast agents
- Uncorrectable coagulopathy or INR >1.5
- Uncorrectable thrombocytopenia (platelet count less than 50,000)
- Open abdomen
- Intra-abdominal sepsis preventing access to the lymphatic system
- Known occlusion of the left subclavian vein
- Known malformation of the lymphatic system
- Need for continuous anticoagulation (that cannot be stopped for procedure)
- Pregnancy
- DNR ('do not resuscitate') status
- Unable to have central venous line or arterial line in place
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
This trial is currently available in United States.
- Hospital of the University of PennsylvaniaPhiladelphia, United StatesContact: Niels D Martin, MDTaking people
About the trial
What the trial wants to find out
To demonstrate that external drainage of thoracic duct lymph during sepsis results in a reduction in circulating pro-inflammatory cytokines.
Read full original descriptionShow less
To demonstrate safety and feasibility of early thoracic duct cannulation and external lymph drainage for up to 7 days in adult surgical intensive care patients.
To explore other biochemical and physiological endpoints that can be used for the design of future randomized controlled trials and estimate effect size of external drainage.
The group in the trial
- Thoracic Duct DrainageTreatment being tested
This is the main study group of patients with thoracic duct drainage
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients: A Pilot Trial With Concurrent Controls to Confirm Safety and Assess Preliminary Efficacy
- Criteria questions
- Built from NCT04855786, who can take part
- Record updated
- 18 February 2026